Pharmaniaga Berhad (KLSE:PHARMA)

Pharmaniaga Berhad Ratios and Metrics

Market cap in millions MYR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 5, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,934	512	555	714	969	1,309
Market Cap Growth	294.75%	-7.79%	-22.28%	-26.35%	-25.92%	143.16%
Enterprise Value	2,607	1,709	1,690	1,800	1,749	2,023
Last Close Price	0.29	0.21	0.23	0.32	0.40	0.51
PE Ratio	15.90	3.88	-	-	5.63	47.60
Forward PE	34.71	10.60	24.06	11.24	11.53	20.20
PS Ratio	0.49	0.14	0.16	0.21	0.20	0.48
PB Ratio	4.30	-3.51	-2.02	-2.05	2.06	3.69
P/TBV Ratio	6.97	-	-	-	3.95	9.63
P/FCF Ratio	-	44.46	-	-	-	-
P/OCF Ratio	-	11.99	11.82	-	-	-
PEG Ratio	-	0.60	0.60	0.60	0.60	0.60
EV/Sales Ratio	0.67	0.45	0.50	0.52	0.36	0.74
EV/EBITDA Ratio	15.38	5.92	229.97	32.36	5.22	21.42
EV/EBIT Ratio	19.10	6.55	-	64.27	5.69	29.93
EV/FCF Ratio	-66.32	148.48	-	-	-	-
Debt / Equity Ratio	2.21	-8.17	-4.35	-3.35	1.82	1.89
Debt / EBITDA Ratio	5.86	3.98	65.02	18.83	2.53	6.83
Debt / FCF Ratio	-	103.57	-	-	-	-
Asset Turnover	1.72	1.92	1.81	1.70	2.51	1.72
Inventory Turnover	5.71	5.39	4.60	3.09	4.52	4.03
Quick Ratio	0.57	0.29	0.24	0.19	0.22	0.27
Current Ratio	0.92	0.62	0.55	0.58	1.11	0.78
Return on Equity (ROE)	29.63%	-	-	-1027.82%	41.73%	7.38%
Return on Assets (ROA)	3.76%	8.35%	-0.68%	0.85%	10.01%	2.66%
Return on Invested Capital (ROIC)	7.93%	21.02%	-2.62%	2.76%	16.94%	5.29%
Return on Capital Employed (ROCE)	21.40%	665.10%	23.30%	-12.70%	38.90%	17.50%
Earnings Yield	2.23%	25.77%	-14.45%	-88.23%	17.76%	2.10%
FCF Yield	-2.03%	2.25%	-0.67%	-28.24%	-9.74%	-2.67%
Dividend Yield	-	-	-	5.86%	23.18%	4.27%
Payout Ratio	-	-	-	-	34.24%	95.10%
Buyback Yield / Dilution	-61.41%	-5.38%	-4.40%	-0.05%	-0.04%	-0.33%
Total Shareholder Return	-61.41%	-5.38%	-4.40%	5.82%	23.14%	3.95%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.